Reading causes myopia

Article

Reading may be a risk factor for childhood myopia, according to a study published in the August 2008 issue of the British Journal of Ophthalmology.

Reading may be a risk factor for childhood myopia, according to a study published in the August 2008 issue of the British Journal of Ophthalmology.

Surgeon Cathy Williams of the Centre for Child and Adolescent Health, Bristol Eye Hospital, UK and colleagues aggregated and evaluated data gathered from a birth cohort study and results of tests including school Standardised Assessment Tests (SATS), the Wescher Objective Reading Dimension (WORD) test, verbal and non-verbal IQ tests with likelihood of being myopic (possessing spherical autorefraction of -1.50 D) and parental report of enthusiasm for reading of children aged 7 and 10 years at baseline (n=6871).

At the age of seven, 1.5% of the children were classified "likely to be myopic" by age 10. After adjusting for myopic parents and ethnicity, risk factors for inclusion in this group included good results from reading, maths, WORD and verbal IQ tests, but the single strongest factor predicting likelihood of myopia was whether the child was reported to enjoy reading: children who did so were four times as likely to develop myopia than children who did not enjoy reading.

The researchers concluded that it is likely that reading, or factors associated with reading, play a role in the development of myopia.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.